Uncertainty exists regarding the best way to communicate cardiovascular risk (CVR) to patients, and it is unclear whether the comprehension and perception of CVR varies according to the format used. The aim of the present work was to determine whether a strategy designed for communicating CVR information to patients with poorly controlled high blood pressure (HBP), but with no background of cardiovascular disease, was more effective than usual care in the control of blood pressure (BP) over the course of a year.
A pragmatic, two-arm, cluster-randomized controlled trial was performed. Consecutive patients aged 40–65 years, all diagnosed with HBP in the last 12 months, and all of whom showed poor control of their condition (systolic BP ≥140 mmHg and/or diastolic BP ≥90 mmHg), were recruited at 22 primary healthcare centres. Eleven centres were randomly assigned to the usual care arm, and 11 to the informative intervention arm (Educore arm). At the start of the study, the Educore arm subjects were shown the "low risk SCORE table", along with impacting images and information pamphlets encouraging the maintenance of good cardiovascular health. The main outcome variable measured was the control of HBP; the secondary outcome variables were SCORE table score, total plasma cholesterol concentration, use of tobacco, adherence to prescribed treatment, and quality of life.
The study participants were 411 patients (185 in the Educore arm and 226 in the usual care arm). Multilevel logistic regression showed that, at 12 months, the Educore intervention achieved better control of HBP (OR = 1.57; 1.02 to 2.41). No statistically significant differences were seen between the two arms at 12 months with respect to the secondary outcomes.
Citation: Escortell-Mayor E, del Cura-González I, Ojeda-Ruiz E, Sanz-Cuesta T, Rodríguez-Salceda I, García-Soltero J, et al. (2020) A primary healthcare information intervention for communicating cardiovascular risk to patients with poorly controlled hypertension: The Education and Coronary Risk Evaluation (Educore) study—A pragmatic, cluster-randomized trial. PLoS ONE 15(1): e0226398. https://doi.org/10.1371/journal.pone.0226398
Editor: Yoshihiro Fukumoto, Kurume University School of Medicine, JAPAN
Received: August 7, 2018; Accepted: November 25, 2019; Published: January 23, 2020
Copyright: © 2020 Escortell-Mayor et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: Ethics Committee of the Hospital Universitario Príncipe de Asturias approved this research, including any potential data sharing. There are ethical and legal restrictions on sharing a de-identified data set, data contain clinical sensitive patient information. Data are from the EDUCORE study whose authors may be contacted at firstname.lastname@example.org, who is currently responsible for the EDCUCORE group.
Funding: This study was funded by the Spanish Ministry of Science and Innovation via the Instituto de Salud Carlos III, Subprograma de Proyectos de Investigación en Evaluación de Tecnologías Sanitarias y Servicios de Salud (PI 09/90354), and the Fundación de Investigación e Innovación Biomédica en Atención Primaria (FIIBAP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Most Spanish patients with high blood pressure (HBP) are attended to at primary healthcare centres in the Spanish National Health System. This easy-access first level of assistance provides integrated and continuous care [1–3]. But, it is complex to provide appropriate information to patients in the healthcare environment.
HBP control figures might be improved via the use of effective pharmacological [4,5] and non-pharmacological intervention strategies [6,7]. According to some authors, a major challenge of such interventions is getting the patient on board. Certainly, family doctors need to transmit information on the risks and benefits of treatment alternatives in a rigorous yet understandable fashion . One randomized clinical trial  reported the skill of patients in identifying cardiovascular risk (CVR) factors to improve when communication was made personal. Other authors  have reported that medical professionals normally communicate these risks verbally, using words and or figures; they also indicate, however, that controversy exists regarding the best way to communicate with patients, particularly over whether verbal communication is improved with visual aids.
The effectiveness of different interventions for communicating CVR information and the impact on risk comprehension and intention to modify personal behaviour has been compared in a systematic review . The authors concluded that more clinical trials were needed to determine how graphic aids used in explanations affect the understanding of risk. In one such trial , patients were shown information in different graphic formats and their taking of treatment decisions assessed. It was concluded that pictograms might be the best format, especially when dealing with patients with weak numerical skills.
The Education and Coronary Risk Evaluation (EDUCORE) study aims to examine the importance of using visual information for instructing patients about CVR and its effect on HBP control. The present work compares, in the primary healthcare setting, usual care and a CVR communication strategy with respect to the achievement of good control of HBP in patients in whom this was poorly controlled but who had no cardiovascular disease (CVD).
This work was designed as a pragmatic, two-arm, cluster-randomized controlled trial lasting one year. It was performed in the primary healthcare setting. The health centres (clusters) were the randomized units, and the patients the analysis units. The supporting CONSORT checklist is available as supporting information; see S1 File.
The study was approved by the Ethics Committee of the Hospital Universitario Príncipe de Asturias (2009/24/06) and was registered at ClinicalTrials.gov (NCT01155973) Specifics of the methodology followed can be found in the study protocol ; see S2 File. There were no deviations from this study protocol.
Twenty-two health centres in eight municipalities representative of the Madrid Region (Madrid City, Torrejón de Ardoz, Alcalá de Henares, Alcobendas, Fuenlabrada, Leganés, Pinto and Getafe) were selected on the basis of their being teaching centres and/or their having participated before in research studies. All the health professionals involved in the study at these centres volunteered their efforts.
The study patients were aged 40–65 years; all were recruited between June 29, 2010, and August 11, 2011 and completed the follow-up one year later.J All had received a diagnosis of HBP in the previous 12 months, and in all it was poorly controlled (systolic blood pressure (SBP) ≥140 mmHg and/or diastolic blood pressure (DBP) ≥90 mmHg; these criteria have remained unchanged across Europe for some years ). Patients with CVD and diabetes mellitus were excluded.
The sample size was determined contemplating a 15% greater increase in the number of patients showing good HBP control in the intervention arm than in the usual care arm, and α value of 0.05, and for a power of 80%. According to data from Spanish studies, good control of SBP and DBP is around 41.4% of patients. The minimum sample size was corrected for the design effect contemplating an intraclass correlation coefficient of 0.03 , and assuming a mean cluster size of 30 patients. The final sample size required was 736 patients, assuming 10% loss to follow-up over the study period.
The 22 health centres (clusters) were assigned by simple randomization to the usual care arm or the information intervention arm—the Educore arm—by an independent statistician using Epidat 3.1 software (n = 11 in each arm). The health professionals at the centres then recruited patients in a consecutive fashion and doctors requested their informed written consent to participate. The same health professionals collected data on their age, sex, and professional category. The mean total number of patients seen per day at each health centre over 2011 was also recorded. These data were used to describe health centres’ characteristics.
The Educore intervention is complex in its nature . It is directed towards patients with poorly controlled HBP and involves the visualization of risk via the "low risk Systematic Coronary Risk Evaluation (SCORE) table" , and through impacting images highlighting CVR. Information pamphlets were also provided that contained their SCORE table score, along with advice for maintaining good cardiovascular health. “Fig 1” describes both arms of the study in the manner currently recommended .
The main outcome variable was good control of HBP (deemed to be good when SBP was <140 mmHg and DBP <90 mmHg). Two blood pressure (BP) readings separated by 2 minutes were taken at sitting position after a minimal resting of 5 minutes using a manually calibrated sphygmomanometer (following the clinical practice guidelines in Servicio Madrileño de Salud). If the readings were very different additional measurements were taken. For the trial an average value of the systolic and diastolic blood pressure was calculated. The secondary outcome variables were systolic BP (SBP) and diastolic BP (DBP), absolute SCORE table score, the plasma cholesterol concentration, use of tobacco, and compliance with treatment (as determined by the Morisky-Green questionnaire ), and mean quality of life as measured by the MINICHAL questionnaire [19,20]. The sociodemographic variables recorded were sex, age, level of education and physical activity undertaken. The anthropometric/clinical variables recorded were body mass index, consumption of antihypertension and lipid-lowering drugs, and any changes in treatment (with their motives).
Patient personal data were collected during clinical interviews lasting 10–30 min in the participating health professionals' offices. Results were recorded in an electronic data storage notebook at 0, 6 and 12 months—except SBP and DBP which were recorded at 0 (baseline), 3, 6, 9 and 12 months. The period of follow-up ended in December of 2012.
A descriptive analysis (means, medians, frequencies of distribution) was made of the healthcare centres and of the characteristics of the patients in each study arm.
The results for the primary outcome variable were analysed for intention to treat (ITT).
Missing values for the main outcome variable were added using the 'last observation carried forward' (LOCF) method . Per protocol (PP) data analysis was also performed for the patients remaining in the study at 12 months.
Multilevel logistic regression analysis was performed to examine the control of HBP achieved in each arm. The dependent variable was good/bad control of HBP at 12 months, and the independent variable the intervention group to which each patient belonged. Additionally, the analysis included the covariates gender, age, and clinically important variables (baseline DBP, use of tobacco, body mass index, cholesterol level, and current antihypertensive treatment). Multilevel models are particularly appropriate when individuals cluster within groups and these groups share characteristics. To take into account this hierarchical structure, random effect terms are introduced to allow the effect of the different levels (in this case the health centres) to be estimated. Fixed effect variables can also be included. The random effect was quantified via the median OR (MOR) between centres, interpreted as the expected change (in medians) in good control of HBP for a patient who switches from one health center to another with increased risk.
Models were estimated using adaptive Gaussian quadrature with seven quadrature points per level. The likelihood ratio test was used to compare the models and assesses the goodness of fit .
The effect of the Educore intervention on the secondary outcome variables (SBP/DBP, CVR, cholesterol levels, use of tobacco, compliance with treatment, and quality of life) were determined at 12 months using appropriate multilevel statistical tests for comparation between arms (multilevel mixed-effects linear regression and multilevel mixed-effects logistic regression).
Significance was set at p<0.05. All calculations were made using SPSS 21 and STATA 14 software.
The final study sample included 411 patients, 226 in the usual care arm and 185 in the Educore arm. At 6 months, 86% of the patients remained in the study, falling to 70% at 12 months (289 patients). The median number of patients recruited per health centre was 16 for the Educore arm and 20 for the usual care arm. “Fig 2” shows the flow diagram for the patients entering each arm, and those remaining at each data collection point, according to the recommendations for presentations made by the CONSORT-Cluster Group .
The number of participating health professionals at the 21 health centres was 120 (65 family doctors and 55 nurses) “Table 1”.
The mean age of the patients was 55.3±6.7 years; 51.6% were women. At the start of the study, 15.4% of the patients were SCORE classified as being at high or very high risk; 67.3% had high plasma cholesterol (mean 214.1 mg/dl), and 25.1% declared themselves smokers. With respect to quality of life, the mean mood score was 4.5 (on a scale of 0–30 from better to worse), and the mean somatic manifestation score was 2.2 (on a scale 1–18 from better to worse). 23.1% of the patients initially took no antihypertension medication; 44% were on monotherapy, and 40% took two or more medications.
The most commonly prescribed medications were angiotensin-converting-enzyme inhibitors (ACE inhibitor), diuretics and angiotensin II receptor blockers (ARBs). Under 15% of the patients took beta-blockers. 39.7% patients received more than one class of antihypertensive medication and 11.2% received more than two. No statistical significance difference were found between groups. The most common combined treatment found was ACE inhibitor+ Diuretics (11.7%). Almost 20% had been prescribed lipid-lowering drugs. Some 70% of patients declared their adherence to pharmacological treatment. “Table 1” shows the baseline values for the cluster, medical personnel and patient variables for both arms of the trial.
The control of HBP improved in both arms at 6 and 12 months (55.7% and 67.6% respectively in the Educore arm [p<0.001 between these two time points], and 50.4% and 58.8% respectively in the control arm [p<0.001 between these two time points]; ITT analysis). “Table 2” shows the results for the control of HBP for both the per protocol and ITT analyses at 6 and 12 months; without adjustment for any factor, the improvements observed do not differ significantly. However, after adjusting for age, baseline SBP and plasma cholesterol, the Educore intervention was associated with better control of HBP at 12 months (OR 1.57; 95%CI (1.02–2.41)). The MOR (median odds ratio) between centres was 1.14, which can be interpreted as the median odds ratio of good control of HBP across all patients in different health centres (comparing the higher risk to lower risk centres). The MOR of 1.14 is lower than the intervention OR, suggesting that variation between health centres contributed less to good control of HBP than did the intervention. “Table 3”.
In both arms, significant reductions in SBP and DBP were achieved over time “Table 4”, but with no significant difference between the arms.
The mean SCORE table score fell from a 2.5 in both arms (baseline) to 2.0 in the Educore arm and 2.1 in the usual care arm at 12 months. At 12 months, no patient was at very high CVR in either arm.
A positive intervention effects at 12 months, according to multilevel regression analysis, over all secondary outcomes except mental status del Mini-CHAL was found. However, these differences were not statistically significant. Table 5
Main findings of the study
A large number of patients in each arm achieved good control of their HBP by 12 months; before adjusting for any influencing variables, no significant differences were seen between the arms. However, after adjusting for age, baseline cholesterol level, and baseline BP, the subjects in the Educore arm were more likely to have achieved good control of their HBP at this time (OR 1.57; 95%CI (1.02–2.41); ITT analysis). The good results obtained in both arms might be explained by patient motivation, the interest shown by the health professionals in improving their clinical practice, or because of the Hawthorne effect, i.e., the feeling of being observed spurring the medical professionals and/or patients to make greater efforts.
No significant differences were seen at any time point between the Educore and usual care arms in terms of any secondary outcome variable.
Strengths and limitations
According to the indications of the PRECIS tool , the design of the study was pragmatic. This is further highlighted in that the results were of importance to the patients involved. The patients all had poorly controlled HBP, and all were recruited at primary healthcare centres where all were treated. The present intervention was independent of the therapeutic regimen prescribed, and in purely clinical terms the prescribing doctors in all cases followed the usual practice for the care of such patients. It is normal for patients with HBP to come for 6-monthly check-ups—more often if control remains poor (and allowed under the present trial conditions). The results for the main outcome variable—good control of HBP at 12 months—were subjected to per protocol and ITT analysis.
Before the study started, the medical professionals assigned to the Educore arm attended a training session during which they were given instructions to facilitate the passing of information on CVR to their patients at their baseline visit. However, in order for the follow-up period to be as similar as possible to everyday practice, it was left up to them to decide whether to provide reinforcement at the 6 and 12 month visits. The results obtained therefore reflect those that might be obtained in real clinical practice.
The study suffers from several limitations. First, since the trial could not be performed blind, there may have been contamination between patients . For this reason a cluster study design was chosen. Second, the health centres were not chosen randomly but for the sake of convenience; all had previously been involved in research and/or were teaching centres. This, it was believed, would help ensure the motivation of their staff (who were not compensated economically in any way), help ensure adequate recruitment, and minimise losses to follow-up. Third, there may have been some bias in the selection of the patients; because -the patients were recruited after the health professionals were informed of their centre assignment. However, since an improvement was seen in both arms, this potential bias seems not to have had much effect. Fourth, difficulties arose during the study recruitment. Most of patients with HBP who presented poor control had diabetes mellitus or CVD (exclusion criteria). At the beginning, to promote the involvement of the professionals and to achieve an adequate recruitment, the health centres were selected for convenience and the professionals were volunteers. However, a significant percentage of professionals abandoned their participation in the study for reasons unrelated to the development of the study (changes of professionals between centres). This affected several of the participating professionals who could not be replaced in that phase of the study.
Fifth, in line with the pragmatic nature of the study, BP measurements were obtained as part of normal practice. The results obtained were therefore open to operator variation, i.e., between the people taking the measurements. Similarly, the doctors who participated recruiting patients were also those who treated them and who applied the intervention protocol. Sixth, it must be assumed that some heterogeneity existed between the participating physicians with respect to the time spent by each in delivering the information.
Finally, only 70% of the patients finished the study. Given the assumption of a 10% loss to follow-up, the final sample was smaller than that hoped for, reducing the power of the conclusions that can be drawn. It has been suggested , however, that with 30% 'missing completely at random' data, any estimation for an effect is very similar to that which would be obtained if all the data were available. In the present work, the differences between the results for the per protocol and ITT analyses were very small.
Comparison with other studies
In a trial involving non-pharmacological interventions aimed at improving the control of HBP in patients in whom it was uncontrolled , improvements were also seen in both the intervention and control arms, with no significant differences between them. However, unlike that seen in the present work, the percentage control achieved in this earlier trial did not surpass 50% in either arm.
In another study , the control of HBP at 12 months of follow-up in patients with diabetes and HBP reached 22% in the group structured intervention arm, and 12% in the control arm. The improvement in SBP and DBP was slightly lower than that seen in the present study in both arms. Other authors  have reported a difference of 20.6% in the increase of patients achieving control over their HBP (multicomponent intervention compared with usual care).
The challenge in communicating risk to patients is to make the information provided understandable, usable and relevant [28,29]. It has been suggested  that one should exercise caution when providing information since the capacity of different people to absorb it will naturally vary. It may be a good idea to try to provide comparisons that can facilitate comprehension, for example by comparing the risk of a car crash to the risk of suffering a cerebrovascular accident in patients with atrial fibrillation. One study performed in the primary setting  reported that the majority (73%) of family doctors communicated CVR to their patients verbally, but it was found that patients understood this information better if it was presented in visual and numerical formats. Other authors  report that patients who receive written information (e.g., pamphlets) achieve a greater level of understanding than those who do not receive such-formatted information, and this information can be more effective if illustrations and graphs are used. Still others  indicate that the comprehension of risk by patients is rarely checked, leading to a lack of adherence to the recommendations given.
Implications of the study findings
In conclusion, both usual care and the Educore intervention improved the percentage of patients with good control of their HBP at 12 months. However, after adjusting for age, baseline cholesterol level, and baseline BP, the subjects in the Educore arm were more likely to have achieved good control of their HBP at this time. It should be remembered, in this context, that the risk associated with an increase in BP is continuous; a 2 mmHg increase in SBP is associated with a 7% increase in the risk of mortality by myocardial infarction, and a 10% increase in the risk of mortality by cerebrovascular accident . In the present work, a mean reduction in SBP of 16 mmHg was seen in the Educore intervention arm compared to 15 mmHg in the usual care arm.
Moreover, the differences observed between groups were small because, as we said, the design of the study was pragmatic. The Spanish National Health System could be another reason. The usual care in primary healthcare for patients with HBP is protocolized and includes standardized information for the patient that could be sufficient. Possibly in subgroups of patients with worse BP control, the Educore intervention could provide greater benefit.
The Educore intervention can easily be integrated into usual practice, and has no associated risks. It is possible that the smaller-than-expected size of the difference observed between the present trial arms was due to the doctors in the usual care arm modifying their practice (perhaps the consequence of their knowing they were involved in a trial). However, the results suggest that providing patients with visual information about CVR, for example by revealing them their SCORE rating, facilitates their achieving control over their HBP. More research might determine whether reinforcement of the intervention message can improve results further.
S1 File. CONSORT checklist (cluster randomized trial).
Esperanza Escortell- Mayor passed away before the submission of the final version of this manuscript. Isabel del Cura-González accepts responsibility for the integrity and validity of the data collected and analysed.
- To Rocío González-González (randomization and depuration data); Juan A. López- Rodríguez (bibliography references support); Víctor Abraira and Jesús Martín-Fernández (analysis review).
- To our colleagues from the Research Unit for their support: Marcial Caboblanco-Muñoz, Juan Carlos Gil-Moreno, Isabel Morales-Ropero, Jaime Barrio-Cortés, Cristina Lozano-Hernández, and Airam Cabrera Rodríguez.
- To Marta García-Solano; Susana Monge-Corella; Sonia Soto-Díaz; Francisco Rodríguez-Salvanés and Ángel Asúnsolo-del-Barco for their initial support.
- To all the professionals from the participant Primary Healthcare Centres.
- To all patients for their contribution to this research.
Clinical Investigators in Primary Healthcare Centres (PHC) Educore study:
PHC La Veredilla (Torrejón de Ardoz. Madrid. Spain): Isidro Rodríguez-Salceda (Manager); Alicia Jorge-Formariz; Roberto Carrascoso-Calvo; Inés Olga Bermejo-Mayoral; María Luisa Lavilla-Arnal; Milagros Juaristi-Lascurain; Carmen Yáñez-Campos; Elena Rodríguez-Quiroga; Rosa Blanca Pérez-García; Mª del Carmen Metola-Serrano; Raúl Ramírez-Gutiérrez; Mercedes Fernández-Ortega; Ana María Gómez-Calvo; Carmen Alonso-Villagra; Mª Antonia Torrenova.
PHC Santa Isabel (Leganés. Madrid. Spain): Pedro Herrera-Municio (Manager); Jesús García-Soltero; Josefina Galán-Esteban; Rosa María Villena-Romero; Sandra García-Casasola; Antonio Redondo-Horcajo; Elisabeth Nieto-Villalón; Rosa Fernández-García; Ángel Delgado-Delgado; Nazareth González-Sánchez; Francisco Alba; Carlos Vicente-Sánchez.
PHC Parque Loranca (Fuenlabrada. Madrid. Spain): Paz Vítores-Picón (Manager); Mª José Rojas-Giraldo; Marta Núñez; Marisa Herrera-García; Luis Pastor; Gema Téllez; Susana Hernández; Mª Luisa Quilchano; Arturo Rodríguez; Mª Ángeles Vilches.
PHC Alcalá de Guadaira (Madrid. Spain): Ángela Lorenzo-Lobato (Manager); Ángeles Isabel Tolosa-Montón; Silvia Colinas-Alonso; Diego José Villalvilla-Soria.
PHC Sector 3 (Getafe. Madrid. Spain): Mª Dolores de-la-Fuente-Arriaran (Manager); Ana Pavón-Conde; Carmelina Sanz-Velasco; Encarnación González-Ortega; Josefa Vázquez-Gallego; Alicia Marqués-Rebollo.
PHC Manuel Merino (Alcalá de Henares Madrid. Spain): Gloria de-la-Sierra-Ocaña (Manager); Mercedes Araujo-Calvo; Jesús Miguel Rodríguez-Collada; Angustias Atienza-Panadero; Elena Yubero-Esteban; Jorge Geanini-Torres.
PHC Fresnos (Torrejón de Ardoz Madrid. Spain): Mª Encarnación Serrano-Serrano; Ana Herrero-Fuentes (Manager); Julia Torres-Morales; Encarnación Tornay-Muñoz.
PHC Andrés Mellado (Madrid. Spain): Juan Carlos Recio-Velasco (Manager); Laura Martín-Arribas.
PHC Águilas (Madrid. Spain): Marta Sanz-Sanz.
PHC Mar Báltico (Madrid. Spain): Esperanza Villar-Coloma (Manager); Isabel Agudo-González; Ainhoa Camarero-Miguel; Carmen Calvo-Torres; Marta Maestre-Casadomet; Juan Camarero-Palacios; Isabel García-del-Río; José Carlos Villalba-González; Mª José Hernández-Yela.
PHC Francia (Fuenlabrada. Madrid. Spain): Ernesto Cerrada-Cerrada (Manager); Mª Eugenia Hernaiz-Casas; Marisa Valles-Ugarte; Mª Carmen Morales; Andrés Téllez; Rafael Camps.
PHC Pavones (Madrid. Spain): Mercedes Ibáñez-Brillas (Manager); Inmaculada Hernández-Beltrán; María Huertas-Uhagón; Juan Ramón Iglesias-Quintana; Eloisa Llanio-Carralero; Lucia Nicolau-Castro.
PHC Fronteras (Torrejón de Ardoz. Madrid. Spain): Ana Muñoz-Cildoz; Alberto de-Miguel-Ballano (Manager); Magdalena Sánchez-Cabañas; Aurora Maestro-Martín; Montserrat Sanz-Herrero; Ana Belén Martínez-Rubio; Pedro Pablo Sánchez-De-La-Calle; Mª Inmaculada García-García; Tamara Rodríguez-Peral; Mª Isabel Peláez-Parra.
PHC Pinto (Pinto Madrid. Spain): Beatriz Herrera-Sánchez (Manager). José Antonio Tena-Martínez; Antonio Ruiz-García; María Teresa Sánchez-López.
PHC Panaderas (Fuenlabrada. Madrid. Spain): Mª Teresa Gordillo-de-la-Cruz (Manager). Cristina Ramos-Díaz; María Alonso-Ovies; Josefa Fernández-García.
PHC Mª Jesús Hereza (Leganés. Madrid. Spain): Mª Jesús Bedoya-Frutos (Manager); Raquel Vignolo-Román; María Luisa Illescas-Sánchez; Orquídea Sales-Aguade.
PHC Dr. Mendiguchía-Carriche (Leganés. Madrid. Spain): Eduardo Díaz-García (Manager); Gema Vázquez-Salado; Mª del Mar Rubio-Moreno; Belinda Pinel-Vaquerizo; Gerardo García-Sánchez; Marta Álvarez-de-la-Riva.
PHC Artilleros (Madrid. Spain): Riansares López-Palomar (Manager); Mª Begoña Ayuso-de-la-Torre.
PHC Maqueda (Madrid. Spain): Esther Arrojo-Arias (Manager); Esther Blázquez-Hernández; Cristina Mora-Casado; Ana Campillo-Palomo.
PHC Mª Ángeles López Gómez (Leganés. Madrid. Spain): Julio Sánchez-Salvador (Manager); Beatriz López-Serrano; Luz Divina Torres-Romo; Arancha Martín-Ramos.
PHC Mª Guzmán (Alcalá de Henares. Madrid. Spain): José Mª Martín-Moros (Manager); Mª Luisa Patón-Cueva
This work was awarded the Best Oral Communication prize at the Congreso Nacional semFyC 2013.
- 1. Starfield B, Shi L, Macinko J. Contribution of primary care to health systems and health. Milbank Q. 2005;83: 457–502. pmid:16202000
- 2. Green L, Fryer G, Yawn B, Lanier D, Dovey S. The ecology of medical care revisited. The New England journal of medicine. 2001. pp. 2021–2025. pmid:11430334
- 3. Zabaleta-del-Olmo E, Bolibar B, García-Ortíz L, García-Campayo J, Llobera J, Bellón JÁ, et al. Building interventions in primary health care for long-term effectiveness in health promotion and disease prevention. A focus on complex and multi-risk interventions. Prev Med (Baltim). 2015;76: S1–S4. pmid:25778858
- 4. Whelton PK, Carey RM, Aronow WS, Ovbiagele B, Casey DE, Smith SC, et al. 2017 ACC / AHA / AAPA / ABC / ACPM / AGS / APhA / ASH / ASPC / NMA / PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults A Report of the American College of Cardiology / American Heart Association T [Internet]. Journal of American College of Cardiology. 2017.
- 5. NICE. Hypertension in adults: diagnosis and management. Guidel—Summ Clin Guidel Prim care. 2017; 59–65.
- 6. Hackam DG, Quinn RR, Ravani P, Rabi DM, Dasgupta K, Daskalopoulou SS, et al. The 2013 Canadian hypertension education program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2013;29: 528–542. pmid:23541660
- 7. He J, Irazola V, Mills KT, Poggio R, Beratarrechea A, Dolan J, et al. Effect of a Community Health Worker-Led Multicomponent Intervention on Blood Pressure Control in Low-Income Patients in Argentina: A Randomized Clinical Trial. JAMA. 2017;318: 1016–1025. pmid:28975305
- 8. Goodyear-Smith F, Arroll B, Chan L, Jackson R, Wells S, Kenealy T. Patients prefer pictures to numbers to express cardiovascular benefit from treatment. Ann Fam Med. 2008;6: 213–217. pmid:18474883
- 9. Powers BJ, Danus S, Grubber JM, Olsen MK, Oddone EZ, Bosworth HB. The effectiveness of personalized coronary heart disease and stroke risk communication. Am Heart J. Elsevier B.V.; 2011;161: 673–680. pmid:21473965
- 10. Neuner-Jehle S, Senn O, Wegwarth O, Rosemann T, Steurer J. How do family physicians communicate about cardiovascular risk? Frequencies and determinants of different communication formats. BMC Fam Pract. BioMed Central Ltd; 2011;12: 15. pmid:21466686
- 11. Waldron C-A, van der Weijden T, Ludt S, Gallacher J, Elwyn G. What are effective strategies to communicate cardiovascular risk information to patients? A systematic review. Patient Educ Couns. Elsevier Ireland Ltd; 2011;82: 169–181. pmid:20471766
- 12. Hawley ST, Zikmund-Fisher B, Ubel P, Jancovic A, Lucas T, Fagerlin A. The impact of the format of graphical presentation on health-related knowledge and treatment choices. Patient Educ Couns. 2008;73: 448–455. pmid:18755566
- 13. Rodríguez-Salceda I, Escortell-Mayor E, Rico-Blázquez M, Riesgo-Fuertes R, Asúnsolo-del Barco A, Valdivia-Pérez A, et al. EDUCORE project: a clinical trial, randomised by clusters, to assess the effect of a visual learning method on blood pressure control in the primary healthcare setting. BMC Public Health. 2010;10: 449. pmid:20673325
- 14. Adams G, Gulliford MC, Ukoumunne OC, Eldridge S, Chinn S, Campbell MJ. Patterns of intra-cluster correlation from primary care research to inform study design and analysis. J Clin Epidemiol. 2004;57: 785–794. pmid:15485730
- 15. Campbell NC, Murray E, Darbyshire J, Emery J, Farmer A, Griffiths F, et al. Designing and evaluating complex interventions to improve health care. BMJ Br Med J. 2007;334: 455–459. pmid:17332585
- 16. Graham B. Clinical practice guidelines: what are they and how should they be disseminated? Hand Clin. Elsevier Inc; 2014;30: 361–5, vii. pmid:25066855
- 17. Perera R, Heneghan C, Yudkin P. Graphical method for depicting randomised trials of complex interventions. BMJ Br Med J. 2007;334: 127–129. pmid:17235093
- 18. Nogués Solán X, Sorli Redó ML, Villar García J. Tools to measure treatment adherence. An Med Interna. 2007;24: 138–141. pmid:17590137
- 19. Roca-Cusachs À, Badia X, Dalfó A, Gascón G, Abellán J, Lahoz R, et al. Relación entre variables clínicas y terapéuticas y calidad de vida relacionada con la salud en pacientes con hipertensión arterial. Estudio MINICHAL. Med Clin (Barc). 2003;121: 12–17.
- 20. Carvalho M a Silva IB, Ramos SB Coelho LF, Goncalves ID, Figueiredo Neto J a, et al. Quality of Life of Hypertensive Patients and Comparison of two Instruments of HRQOL Measure. Arq Bras Cardiol. 2012;98: 442–450. pmid:22481643
- 21. Salim A, Mackinnon A, Christensen H, Griffiths K. Comparison of data analysis strategies for intent-to-treat analysis in pre-test-post-test designs with substantial dropout rates. Psychiatry Res. 2008;160: 335–345. pmid:18718673
- 22. Rabe-Hesketh S, Skrondal A. Multilevel and Longitudinal Modeling Using Stata. Stata Pres. Texas; 2008.
- 23. Campbell MK, Piaggio G, Elbourne DR, Altman DG. Consort 2010 statement: extension to cluster randomised trials. BMJ. 2012;345: e5661. pmid:22951546
- 24. Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ. 2015;350: h2147. pmid:25956159
- 25. Ma J, Akhtar-Danesh N, Dolovich L, Thabane L. Imputation strategies for missing binary outcomes in cluster randomized trials. BMC Med Res Methodol. 2011;11: 18. pmid:21324148
- 26. O’Connor PJ, Magid DJ, Sperl-Hillen JM, Price DW, Asche SE, Rush W a., et al. Personalised physician learning intervention to improve hypertension and lipid control: randomised trial comparing two methods of physician profiling. BMJ Qual Saf. 2014;23: 1014–1022. pmid:25228778
- 27. Edelman D, Fredrickson SK, Melnyk SD, Coffman CJ, Jeffreys AS, Datta S, et al. Medical clinics versus usual care for patients with both diabetes and hypertension: a randomized trial. Ann Intern Med. United States; 2010;152: 689–696. pmid:20513826
- 28. Naik G, Ahmed H, Edwards AG. Communicating risk to patients and the public. Br J Gen Pract. 2012;62: 213. pmid:22520906
- 29. Manganello J a., Clayman ML. The Association of Understanding of Medical Statistics with Health Information Seeking and Health Provider Interaction in a National Sample of Young Adults. J Health Commun. 2011;16: 163–176. pmid:21951250
- 30. Edwards A, Elwyn G, Mulley A. Explaining risks: turning numerical data into meaningful pictures. BMJ. 2002;324: 827–830. pmid:11934777
- 31. Trevena LJ, Davey HM, Barratt A, Butow P, Caldwell P. A systematic review on communicating with patients about evidence. J Eval Clin Pract. 2006;12: 13–23. pmid:16422776
- 32. Persell SD, Eder M, Friesema E, Connor C, Rademaker A, French DD, et al. EHR-based medication support and nurse-led medication therapy management: rationale and design for a three-arm clinic randomized trial. J Am Heart Assoc. 2013;2: e000311. pmid:24157649